Get the Stockscreener App
17.91
1.02%
-0.185
After Hours:
17.92
0.005
+0.03%
Staar Surgical Co stock is traded at $17.91, with a volume of 587.93K.
It is down -1.02% in the last 24 hours and up +6.76% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
See More
Previous Close:
$18.10
Open:
$17.97
24h Volume:
587.93K
Relative Volume:
0.77
Market Cap:
$887.26M
Revenue:
$341.22M
Net Income/Loss:
$21.78M
P/E Ratio:
40.72
EPS:
0.44
Net Cash Flow:
$26.30M
1W Performance:
-5.61%
1M Performance:
+6.76%
6M Performance:
-25.94%
1Y Performance:
-56.57%
1-Day Range:
$17.48
$18.07
1-Week Range:
$17.48
$19.52
52-Week Range:
$13.50
$41.19
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
17.91 | 896.42M | 341.22M | 21.78M | 26.30M | 0.44 |
|
ISRG
Intuitive Surgical Inc
|
481.09 | 179.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
178.25 | 52.03B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.55 | 44.11B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
271.94 | 40.68B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
239.26 | 17.92B | 2.90B | 467.20M | 306.90M | 6.37 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
STAAR Surgical Earnings: Global Vision Correction Leader Sets Q2 2025 Financial Results Date - Stock Titan
Why STAAR Surgical Company stock attracts strong analyst attentionTechnical Chart Summary for Momentum Stocks - Newser
How STAAR Surgical Company stock reacts to Fed policy changesDaily Market Momentum and Pressure Analysis - Newser
Is STAAR Surgical Company stock overvalued or undervaluedMaximize gains with data-driven stock picks - jammulinksnews.com
Why is STAAR Surgical Company stock attracting strong analyst attentionRapidly growing investment returns - jammulinksnews.com
Moving Average Trends for STAAR Surgical Company Stock: What They IndicateFree Risk Assessment Services - Newser
STAAR Surgical Company (NASDAQ:STAA) Shares Sold by Bank of New York Mellon Corp - Defense World
STAAR Surgical Company Stock Analysis and ForecastMarket-crushing stock picks - Autocar Professional
What analysts say about STAAR Surgical Company stockMarket-crushing profits - PrintWeekIndia
What drives STAAR Surgical Company stock priceRapidly expanding wealth - Autocar Professional
STAAR Surgical Q1 2025 slides: China disruption impacts revenue, global markets show growth - Investing.com
STAAR Surgical Q1 2025 slides: China disruption impacts revenue, global markets show growth By Investing.com - Investing.com South Africa
The penetration of refractive procedures in various markets - EyeWorld
STAAR Surgical (STAA) Stock Is Up, What You Need To Know - Yahoo Finance
Is STAAR Surgical Company a good long term investmentAccelerated earnings growth - PrintWeekIndia
STAAR Surgical (NASDAQ:STAA) and CONMED (NYSE:CNMD) Head-To-Head Contrast - Defense World
STAAR Surgical (NASDAQ:STAA) Price Target Raised to $18.00 - Defense World
Midday Stock Roundup: loanDepot Up 10% with High Volume - Orange County Business Journal
Deborah Andrews Appointed CFO at STAAR Surgical - Medical Product Outsourcing
Principal Financial Group Inc. Raises Position in STAAR Surgical Company (NASDAQ:STAA) - Defense World
Implantable Collamer Lens Market is expected to reach US$ 810 - openPR.com
3 Reasons to Sell STAA and 1 Stock to Buy Instead - Yahoo Finance
STAAR Surgical (NASDAQ:STAA) vs. Golf Rounds.com (OTCMKTS:FZMD) Head-To-Head Comparison - Defense World
Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo
Staar Surgical Co. Reaches Analyst Target Price - Nasdaq
Intraocular Lens Market The Future of Industry: Promising Innovations (2025-2032) - newstrail.com
Wealth Enhancement Advisory Services LLC Purchases 9,125 Shares of STAAR Surgical Company (NASDAQ:STAA) - Defense World
Head to Head Comparison: STAAR Surgical (NASDAQ:STAA) and McKesson (NYSE:MCK) - Defense World
STAAR Surgical’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
State of Alaska Department of Revenue Sells 710 Shares of STAAR Surgical Company (NASDAQ:STAA) - Defense World
STAAR Surgical appoints Deborah Andrews as CFO - Investing.com
Staar Surgical Holds Annual Shareholders Meeting - TipRanks
Piper Sandler maintains neutral rating on STAAR Surgical stock amid China woes By Investing.com - Investing.com South Africa
Piper Sandler maintains neutral rating on STAAR Surgical stock amid China woes - Investing.com India
Rhumbline Advisers Sells 706 Shares of STAAR Surgical (NASDAQ:STAA) - Defense World
Bright Future: Cataract Surgery Devices Market Soars to $12.2B by 2030 with Innovation - newstrail.com
Staar Surgical Co (STAA) Shares Gap Down to $17.535 on Jun 11 - GuruFocus
STAA Q1 Earnings Call: Tariff Mitigation, Cost Cuts, and China Inventory Reshape Outlook - Yahoo Finance
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 13,075 Shares of STAAR Surgical (NASDAQ:STAA) - Defense World
Intraocular Lens Market Emerging Tech Trends to Watch from 2025 to 2032 - newstrail.com
STAAR Surgical at William Blair Conference: Strategic Shifts Amid Challenges By Investing.com - Investing.com South Africa
STAAR Surgical at William Blair Conference: Strategic Shifts Amid Challenges - Investing.com Australia
Staar Surgical Co (STAA) Trading Down 5.84% on Jun 2 - GuruFocus
Staar Surgical Co (STAA) Trading Down 3.22% on May 30 - GuruFocus
Phakic Intraocular Lens Manufacturing 2025: Market Surge & Innovation Unveiled - macholevante.com
Staar Surgical Co (STAA) Stock Price Down 4.12% on May 28 - GuruFocus
Why LASIK Isn't for Everyone: Houston Lasik & Eye Introduces EVO ICL as a Personalized Solution - USA Today
Canaccord Genuity Maintains Hold Rating for STAA with $20 Price Target | STAA Stock News - GuruFocus
STAAR Surgical (NASDAQ:STAA) Receives Hold Rating from Canaccord Genuity Group - Defense World
STAAR Surgical at Stifel Forum: Strategic Moves and Market Challenges - Investing.com Australia
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
22.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):